EP Patent

EP2578561A1 — Processes for the production of cannabidiol derivatives and intermediates thereof

Assigned to Curia Global Inc · Expires 2013-04-10 · 13y expired

What this patent protects

This invention relates to a process for the preparation of a product compound of the formula: wherein: R 1 is H, substituted or unsubstituted alkyl, carboxylic ester, or acyl; R 2 is H, OH, protected hydroxyl, substituted or unsubstituted alkyl, alkenyl, alkynyl, acyl, …

USPTO Abstract

This invention relates to a process for the preparation of a product compound of the formula: wherein: R 1 is H, substituted or unsubstituted alkyl, carboxylic ester, or acyl; R 2 is H, OH, protected hydroxyl, substituted or unsubstituted alkyl, alkenyl, alkynyl, acyl, aryl, or heteroaryl; R 3 is H, substituted or unsubstituted alkyl, carboxylic ester, or acyl; R 4 is H, substituted or unsubstituted alkyl, silyl, hetero-substituted or unsubstituted acyl, alkylsulfonyl, arylsulfonyl, alkylphosphoryl, or arylphosphoryl; and R 6 is H, substituted or unsubstituted alkyl, silyl, hetero-substituted or unsubstituted acyl, alkylsulfonyl, arylsulfonyl, alkylphosphoryl, or arylphosphoryl.

Drugs covered by this patent

Patent Metadata

Patent number
EP2578561A1
Jurisdiction
EP
Classification
—
Expires
2013-04-10
Drug substance claim
No
Drug product claim
No
Assignee
Curia Global Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.